Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
LL-37 structure

LL-37

Immune
Phase 1 Research
35%
Low-Moderate Risk
2/5

Warnings

May cause significant local reactions
Research compound only

Contraindications

PregnancyBreastfeeding

Possible Side Effects

Injection Site ReactionsRednessSwelling

Legal & Regulatory

FDA Status Research Only
WADA Status Not Prohibited
Prescription Not Required

Pregnancy

Not Rated